Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
about
Peptide Markers for Rapid Detection of KPC Carbapenemase by LC-MS/MS.Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015.Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying blaKPC Collected in U.S. Hospitals from 2012 to 2015.The epidemiology of carbapenemases in Latin America and the Caribbean.In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae.In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, Against Carbapenem-Non-Susceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014-2016.In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study).Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China
P2860
Q33746886-51331812-A7D4-4D16-8A8F-2A1AB45C8E25Q38738509-6E55AD5E-6B8F-4C6E-9C34-D71257644203Q40166206-F097C7D0-889E-4218-9199-4FE831A0DA92Q40392503-1F791B6E-2DA8-464F-AE45-184C886A402DQ40424743-1DBBCA1F-BC1F-4B8C-838B-393DD95618D0Q47129277-FF703C3E-F3D6-4AB3-9198-3601BC91D3F5Q47211519-309A05EA-350D-4E6C-8B9B-73F17FF0D605Q47341827-317F90C0-0A00-44D3-9A00-BDDDE87A9BE2Q52577425-9BD77906-D76F-465C-BAC7-8AB3DDC9B930Q52695014-B3925151-90D7-4028-B63F-0EFDB9B80DC1Q57211457-6215BFA7-B641-493D-9B58-D81972AF2ABCQ58720574-4BF7A6A6-EEFC-4985-906C-656FC516B26F
P2860
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global Dissemination of blaKPC ...... bactam and Aztreonam-Avibactam
@en
Global Dissemination of blaKPC ...... actam and Aztreonam-Avibactam.
@nl
type
label
Global Dissemination of blaKPC ...... bactam and Aztreonam-Avibactam
@en
Global Dissemination of blaKPC ...... actam and Aztreonam-Avibactam.
@nl
prefLabel
Global Dissemination of blaKPC ...... bactam and Aztreonam-Avibactam
@en
Global Dissemination of blaKPC ...... actam and Aztreonam-Avibactam.
@nl
P2093
P2860
P356
P1476
Global Dissemination of blaKPC ...... bactam and Aztreonam-Avibactam
@en
P2093
Boudewijn L M de Jonge
Daniel F Sahm
Douglas J Biedenbach
Krystyna M Kazmierczak
Meredith Hackel
Samuel K Bouchillon
Sharon Rabine
P2860
P304
P356
10.1128/AAC.00107-16
P407
P577
2016-05-09T00:00:00Z